Bionano Genomics
BNGO
29 hedge funds and large institutions have $329K invested in Bionano Genomics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.
13% more capital invested
Capital invested by funds: $291K → $329K (+$38.5K)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
0.83% less ownership
Funds ownership: 3.81% → 2.99% (-0.83%)
3% less funds holding
Funds holding: 30 → 29 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$150K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.61K |
| 4 |
SSG
Summit Securities Group
New York
|
+$4.47K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$139K |
| 2 |
Morgan Stanley
New York
|
-$1.25K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$989 |
| 4 |
BlackRock
New York
|
-$623 |
| 5 |
CCM
Coldstream Capital Management
Bellevue,
Washington
|
-$386 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Fifth Third Bancorp
Cincinnati,
Ohio
| $3 | – | – | – |
|
|
MWA
27
Medallion Wealth Advisors
Farmington,
Connecticut
| $3 | – | – | – |
|
|
AA
28
Ancora Advisors
Cleveland,
Ohio
| $3 | +$4 | +1 | New |
|
|
29
Vanguard Group
Malvern,
Pennsylvania
| – | -$139K | -49,979 | Closed |
|
|
CCM
30
Coldstream Capital Management
Bellevue,
Washington
| – | -$386 | -138 | Closed |
|
|
RA
31
Rise Advisors
Rochester,
New York
| – | -$296 | -106 | Closed |
|
|
FFA
32
Farther Finance Advisors
San Francisco,
California
| – | -$16 | -5 | Closed |
|
33
Barclays
London,
United Kingdom
| – | -$8 | -3 | Closed |
|
34
Fidelity Investments
Boston,
Massachusetts
| – | -$6 | -2 | Closed |
|
BNGO Hedge Fund Activity: Q2 2025 in Review
29 of the 7,599 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2025, worth a combined $329K — up 13% from $291K a quarter earlier.
Fund positioning in BNGO was balanced in Q2 2025: 6 funds opened new positions, 6 closed out, 6 added to existing stakes and 6 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $150K. The largest seller was Vanguard Group, exiting entirely with an estimated $139K sold.
- 29 institutional investors held Bionano Genomics (BNGO) as of Q2 2025, down from 30 in Q1 2025.
- Funds reported $329K of Bionano Genomics stock for Q2 2025, up 13% quarter-over-quarter.
- 6 funds opened new Bionano Genomics positions in Q2 2025 and 6 closed out, a net change of 0 holders.
- The largest Bionano Genomics buyer in Q2 2025 was GSA Capital Partners, an estimated $150K added.
- The largest Bionano Genomics seller in Q2 2025 was Vanguard Group, an estimated $139K sold.
Based on aggregated 13F filings for Q2 2025.